The Fort Worth Press - US panel weighs authorizing Covid vaccines for youngest children

USD -
AED 3.672504
AFN 66.067856
ALL 82.329403
AMD 381.252395
ANG 1.790403
AOA 917.000367
ARS 1440.750402
AUD 1.502178
AWG 1.8
AZN 1.70397
BAM 1.665148
BBD 2.010898
BDT 122.012686
BGN 1.66663
BHD 0.376399
BIF 2951.002512
BMD 1
BND 1.28943
BOB 6.898812
BRL 5.419704
BSD 0.998425
BTN 90.29075
BWP 13.228896
BYN 2.94334
BYR 19600
BZD 2.008003
CAD 1.37795
CDF 2240.000362
CHF 0.795992
CLF 0.023203
CLP 910.250396
CNY 7.054504
CNH 7.05355
COP 3802.477545
CRC 499.425312
CUC 1
CUP 26.5
CVE 93.878507
CZK 20.669104
DJF 177.795752
DKK 6.361804
DOP 63.471117
DZD 129.660125
EGP 47.313439
ERN 15
ETB 156.002554
EUR 0.851404
FJD 2.271804
FKP 0.747509
GBP 0.747831
GEL 2.703861
GGP 0.747509
GHS 11.461411
GIP 0.747509
GMD 73.000355
GNF 8683.325529
GTQ 7.647184
GYD 208.879997
HKD 7.78025
HNL 26.285812
HRK 6.417704
HTG 130.867141
HUF 327.990388
IDR 16633.75
ILS 3.222795
IMP 0.747509
INR 90.570104
IQD 1307.905155
IRR 42122.503816
ISK 126.403814
JEP 0.747509
JMD 159.856966
JOD 0.70904
JPY 155.76504
KES 128.74718
KGS 87.450384
KHR 3997.275552
KMF 419.503794
KPW 899.996355
KRW 1474.530383
KWD 0.306704
KYD 0.832063
KZT 520.710059
LAK 21644.885275
LBP 89408.028607
LKR 308.509642
LRD 176.22068
LSL 16.844664
LTL 2.95274
LVL 0.60489
LYD 5.423354
MAD 9.185305
MDL 16.877953
MGA 4422.970499
MKD 52.403048
MMK 2099.82189
MNT 3545.972795
MOP 8.006045
MRU 39.956579
MUR 45.920378
MVR 15.403739
MWK 1731.301349
MXN 18.013904
MYR 4.097304
MZN 63.910377
NAD 16.844664
NGN 1452.570377
NIO 36.745988
NOK 10.137304
NPR 144.46554
NZD 1.72295
OMR 0.384504
PAB 0.998425
PEN 3.361458
PGK 4.303776
PHP 59.115038
PKR 279.805628
PLN 3.59745
PYG 6706.398195
QAR 3.638755
RON 4.335904
RSD 99.936146
RUB 79.673577
RWF 1453.152271
SAR 3.752205
SBD 8.176752
SCR 15.027038
SDG 601.503676
SEK 9.269904
SGD 1.292104
SHP 0.750259
SLE 24.125038
SLL 20969.503664
SOS 569.579839
SRD 38.548038
STD 20697.981008
STN 20.859052
SVC 8.736112
SYP 11056.819441
SZL 16.838789
THB 31.595038
TJS 9.175429
TMT 3.51
TND 2.918735
TOP 2.40776
TRY 42.580368
TTD 6.775361
TWD 31.335104
TZS 2471.074028
UAH 42.185773
UGX 3548.593078
UYU 39.180963
UZS 12028.436422
VES 267.43975
VND 26306
VUV 120.685003
WST 2.775482
XAF 558.475161
XAG 0.016141
XAU 0.000233
XCD 2.70255
XCG 1.799413
XDR 0.694564
XOF 558.475161
XPF 101.536759
YER 238.503589
ZAR 16.87546
ZMK 9001.203584
ZMW 23.038611
ZWL 321.999592
  • RBGPF

    0.0000

    81.17

    0%

  • SCS

    0.0200

    16.14

    +0.12%

  • JRI

    -0.0200

    13.7

    -0.15%

  • BCC

    0.2500

    76.51

    +0.33%

  • NGG

    0.2400

    74.93

    +0.32%

  • BCE

    0.3100

    23.71

    +1.31%

  • CMSC

    -0.1300

    23.3

    -0.56%

  • CMSD

    -0.1500

    23.25

    -0.65%

  • RIO

    -1.0800

    75.66

    -1.43%

  • RELX

    0.1000

    40.38

    +0.25%

  • GSK

    -0.0700

    48.81

    -0.14%

  • AZN

    -0.4600

    89.83

    -0.51%

  • VOD

    0.0500

    12.59

    +0.4%

  • BP

    -0.2700

    35.26

    -0.77%

  • BTI

    -1.2700

    57.1

    -2.22%

  • RYCEF

    -0.2500

    14.6

    -1.71%

US panel weighs authorizing Covid vaccines for youngest children
US panel weighs authorizing Covid vaccines for youngest children / Photo: © AFP/File

US panel weighs authorizing Covid vaccines for youngest children

After months of anxious wait for some parents, a panel of experts convened by the US Food and Drug Administration will meet Wednesday to weigh recommending Covid vaccines for the nation's youngest children.

Text size:

Children under five are the only age group not yet eligible for Covid immunization in the United States and most other countries. If, as expected, panelists vote in favor of greenlighting the Pfizer and Moderna vaccines, formal authorizations should follow quickly, with the first shots in arms expected by next week.

Ahead of the meeting, the FDA posted its independent analyses of the two drugs, deeming both safe and effective. It also said there was a pressing unmet need to inoculate children in the age group since their rates of hospitalization and death "are higher than among children and adolescents 5-17 years of age."

Both vaccines are based on messenger RNA technology, which delivers genetic code for the coronavirus spike protein to human cells, training the immune system to be ready for when it encounters the real virus.

Pfizer is seeking authorization for three doses at three micrograms given to ages six months through four years, while Moderna has asked for the FDA to approve its vaccine as two doses of a higher 30 micrograms, for ages six months through five years.

They were tested in trials of thousands of children where they were found to have similar levels of mild effects to older age groups and triggered similar levels of antibodies.

Efficacy against infection was higher for Pfizer, with the company placing it at 80 percent compared to Moderna's estimates of 51 percent in the six-month-old to age two group and 37 percent in the two to five years age group.

But the figures are provisional and Moderna is studying adding a third dose later that may increase its figures.

There are some 20 million US children aged four years and under. If the FDA-appointed experts recommend the two vaccines, then the matter will go to another committee convened by the Centers for Disease Control and Prevention for a final say.

White House officials last week said the rollout of millions of shots at pharmacies and doctors' offices could begin as soon as June 21, following the Juneteenth holiday on June 20.

Of the total US Covid deaths, 480 have come in children under five, according to the latest official data.

Obesity, neurological disorders and asthma are associated with increased risk of severe disease, "however, a majority of children hospitalized for Covid-19 have no underlying medical conditions," the FDA said in a document.

Children can also go on to contract multisystem inflammatory syndrome in children (MIS-C), a rare but serious post-viral condition.

Data on long Covid in children is sparse, but the FDA's document cited a national survey in the United Kingdom which found that "among children ages two to 11 years who tested positive for COVID-19, 7.2 percent reported continued symptoms at 12 weeks."

H.Carroll--TFWP